Search Results - "Tanas, A.S."

1143P Virtual amplicons for methylation-sensitive restriction enzyme quantitative PCR (MSRE-qPCR) derived from genome-wide DNA methylation sequencing: Application to prediction of breast cancer neoadjuvant chemotherapy response by Kalinkin, A.I., Sigin, V., Ignatova, E., Tanas, A.S., Strelnikov, V.V.

Get full text

17P Cyclophosphamide influence on survival probability of breast cancer patients depending on leukotriene receptor LTB4R gene expression level by Kalinkin, A.I., Sigin, V.O., Tanas, A.S., Strelnikov, V.V.

Get full text

85P - Improving detection level of somatic mosaicism in neurofibromatosis type 1 by Karandasheva, K., Pashchenko, M., Tanas, A.S., Strelnikov, V.V., Kuznetsova, E.

“…Neurofibromatosis type 1 (NF-1) is a tumor predisposition syndrome resulting from mutations in NF1 antioncogene. Differential diagnosis with genetic testing is…”
Get full text

Improving detection level of somatic mosaicism in neurofibromatosis type 1 by Karandasheva, K., Pashchenko, M., Tanas, A.S., Strelnikov, V.V., Kuznetsova, E.

Get full text

Leukotriene B4 receptors abnormal gene expression is associated with either shorter or longer survival in breast cancer patients depending on the intrinsic tumour molecular subtype by Kalinkin, A.I., Nemtsova, M.V., Zaletaev, D.V., Sigin, V.O., Ignatova, E., Kuznetsova, E.B., Strelnikov, V.V., Tanas, A.S.

Get full text

27P Development of DNA methylation markers panels for neoadjuvant chemotherapy response prediction in triple-negative breast cancer by Sigin, V.O., Kalinkin, A.I., Ignatova, E., Chesnokova, G., Vinogradov, I.Y., Vinogradov, I.I., Vinogradov, M.I., Strelnikov, V.V., Zaletaev, D.V., Tanas, A.S.

Get full text

70P A DNA methylation markers panel for prediction of luminal B breast cancer neoadjuvant chemotherapy response by quantitative PCR by Nikolaeva, A., Sigin, V., Kalinkin, A.I., Litviakov, N.V., Slonimskaya, E., Tsyganov, M., Kharitonova, A., Vinogradov, I., Vinogradov, M., Strelnikov, V.V., Tanas, A.S.

Get full text

A seven-gene methylation markers panel: An epigenetic predictor of neoadjuvant chemotherapy sensitivity in triple-negative breast cancer by Sigin, V.O., Kalinkin, A.I., Ignatova, E., Sycheva, A.V., Vinogradov, I.I., Vinogradov, M.I., Vinogradov, I.Y., Zaletaev, D.V., Strelnikov, V.V., Tanas, A.S.

Get full text

A parent-of-origin effect of the RB1 mutations in retinoblastoma with low penetrance and variable expressivity by Alekseeva, E.A., Babenko, O.V., Kozlova, V.M., Ushakova, T.L., Kazubskaya, T.P., Sahakyan, S.V., Tanas, A.S., Zaletaev, D.V., Strelnikov, V.V.

Get full text

1170P - A parent-of-origin effect of the RB1 mutations in retinoblastoma with low penetrance and variable expressivity by Alekseeva, E.A., Babenko, O.V., Kozlova, V.M., Ushakova, T.L., Kazubskaya, T.P., Sahakyan, S.V., Tanas, A.S., Zaletaev, D.V., Strelnikov, V.V.

“…Retinoblastoma (RB) is the most common pediatric intraocular neoplasm caused by the biallelic inactivation of the RB1 tumor suppressor gene. In 40% of cases,…”
Get full text

826P - Identification of a spectrum of germline mutations for hereditary diffuse gastric cancer in the Russian population by next-generation sequencing by Efimova, I.U., Ignatova, E., Bykov, I., Kalinkin, A.I., Tanas, A.S., Alekseeva, E.A., Strelnikov, V.V., Alakunov, A., Kuznetsova, E., Nemtsova, M.V.

“…Gastric cancer is the fifth most common malignancy in the world and the third leading cause of cancer death. Approximately 1–3% of gastric cancers are…”
Get full text

Identification of a spectrum of germline mutations for hereditary diffuse gastric cancer in the Russian population by next-generation sequencing by Efimova, I.U., Ignatova, E., Bykov, I., Kalinkin, A.I., Tanas, A.S., Alekseeva, E.A., Strelnikov, V.V., Alakunov, A., Kuznetsova, E., Nemtsova, M.V.

Get full text

93P IRF4 gene promoter methylation predicts efficacy of luminal B breast tumours neoadjuvant chemotherapy by Sigin, V., Kalinkin, A.I., Litviakov, N.V., Kuznetsova, E., Simonova, O., Volodin, I., Slonimskaya, E., Tsyganov, M., Vinogradov, I.I., Vinogradov, M., Vinogradov, I.Y., Zaletaev, D.V., Strelnikov, V.V., Tanas, A.S.

Get full text

20P - Matrix metalloproteinases and their tissue inhibitors genes abnormal DNA methylation in breast cancer by Simonova, O., Kuznetsova, E., Tanas, A.S., Rudenko, V., Poddubskaya, E., Kekeeva, T., Chesnokova, G., Kutsev, S., Zaletaev, D.V., Nemtsova, M.V., Strelnikov, V.V.

“…Matrix metalloproteinases (MMPs) specifically hydrolyze the extracellular matrix proteins. MMPs are inhibited by tissue inhibitors of MMPs (TIMPs). Changes in…”
Get full text

Matrix metalloproteinases and their tissue inhibitors genes abnormal DNA methylation in breast cancer by Simonova, O., Kuznetsova, E., Tanas, A.S., Rudenko, V., Poddubskaya, E., Kekeeva, T., Chesnokova, G., Kutsev, S., Zaletaev, D.V., Nemtsova, M.V., Strelnikov, V.V.

Get full text

DNA methylation markers of breast cancer response to anthracycline based neoadjuvant chemotherapy by Sigin, V.O., Strelnikov, V.V., Litviakov, N.V., Simonova, O.A., Volodin, I.V., Slonimskaya, E.M., Tanas, A.S., Zaletaev, D.V., Kuznetsova, E.B., Tsyganov, M.M.

Get full text

Epigenomics paves a new way to assess potential toxicity and chemotherapeutic response of breast tumours to 5-fluorouracil by Strelnikov, V.V., Ignatova, E.O., Kekeeva, T.V., Poddubskaya, E.V., Nemtsova, M.V., Kuznetsova, E.B., Zaletaev, D.V., Tanas, A.S.

Get full text

The level of somatic mutations as an indicator of overall survival in gastric cancer by Kekeeva, T., Tanas, A.S., Khashimov, L., Lyadov, V., Andreeva, Y., Frank, G., Zavalishina, L., Zaletaev, D.V., Strelnikov, V.V.

Get full text

PBRM1 is a novel candidate low-penetrance familial cancer predisposition gene by Volodin, I., Kozlova, V.M., Anoshkin, K.I., Tanas, A.S., Zaletaev, D.V., Strelnikov, V.V.

Get full text

XmaI-RRBS DNA methylation screening resolves breast cancer epigenetic heterogeneity by Tanas, A.S., Kekeeva, T., Sigin, V.O., Kuznetsova, E.B., Poddubskaya, E., Trotsenko, I., Zaletaev, D.V., Strelnikov, V.V.

Get full text